Research assistant at University of Arkansas for Medical Science, United States
Dr. Sayed Abdi is a distinguished toxicologist and researcher with a strong academic foundation and extensive international experience. He completed his PhD in Toxicology from Jamia Hamdard University, focusing on chemotherapy-induced urotoxicity and its molecular mechanisms. With over a decade of research and teaching experience, Dr. Abdi has contributed significantly to toxicology, pharmacology, and molecular biology. His work emphasizes developing innovative therapeutic approaches to minimize drug toxicity and improve patient outcomes. Dr. Abdi has held roles in prestigious institutions across India, Saudi Arabia, and the United States, showcasing his adaptability and commitment to advancing scientific knowledge. He has published extensively in peer-reviewed journals and actively participates in collaborative research projects.
Profile
Google Scholar
Education 🎓
Dr. Sayed Abdi’s academic journey is rooted in excellence. He earned his PhD in Toxicology in December 2017 from Jamia Hamdard University, New Delhi, India. His doctoral research focused on the development of murine models to understand chemotherapy-induced hemorrhagic cystitis. He holds a Master’s degree in Pharmacy Practice from JSS College of Pharmacy, Mysore, completed in March 2011. His undergraduate degree in Pharmacy was also obtained from Jamia Hamdard University in December 2008. This robust academic background has equipped him with the theoretical and practical expertise required for cutting-edge research in toxicology, pharmacology, and molecular biology.
Work Experience 💼
Dr. Abdi’s professional experience spans diverse roles in academia and research. As a Research Assistant II at the University of Arkansas, he performs laboratory experiments and clinical trials of nutraceuticals. Prior roles include Research Assistant at the University of Tennessee, where he conducted molecular biology experiments and mouse behavioral studies, and a Postdoctoral Fellow at the Medical College of Wisconsin, focusing on NGS and RNA sequencing. From 2018 to 2022, Dr. Abdi served as an Assistant Professor at Al-Baha University, Saudi Arabia, mentoring students and conducting computational modeling, molecular dynamics simulations, and disease model development. His global career reflects a commitment to advancing toxicology and molecular biology research through collaborative and innovative projects.
Awards and Honors
Dr. Abdi’s dedication to research and teaching has earned him recognition in academia. While specific awards are not detailed, his global academic and research roles at prestigious institutions reflect his reputation as a highly skilled researcher. His contributions to understanding chemotherapy toxicity and therapeutic interventions are widely acknowledged. Additionally, his ability to secure research positions in top institutions like the University of Arkansas, University of Tennessee, and Al-Baha University demonstrates his academic excellence and professional commitment. Dr. Abdi’s impactful publications further underscore his expertise and dedication to advancing toxicology and pharmacology.
Research Interests
Dr. Abdi’s research interests revolve around molecular toxicology, pharmacology, and the development of therapeutics to mitigate chemotherapy-induced side effects. His work on cyclophosphamide-induced urotoxicity highlights his dedication to understanding drug toxicity at the molecular level. He is also passionate about natural antioxidants as potential therapeutic agents, bridging the gap between pharmacology and nutraceuticals. His interests extend to computational biology, exploring protein modeling, molecular docking, and dynamics simulations to predict therapeutic targets. With a strong focus on clinical applications, Dr. Abdi aims to develop innovative solutions that enhance drug safety and efficacy, contributing to improved patient outcomes.
Research Skills
Dr. Abdi is proficient in various advanced research techniques. His molecular biology expertise includes PCR, qRT-PCR, Western blotting, and RNA sequencing. In toxicology, he specializes in developing murine disease models, drug safety studies, and chemokine/cytokine analysis. He is skilled in flow cytometry for cell analysis and sorting, as well as tissue culture techniques for cytotoxicity assays. His computational biology skills encompass molecular docking, dynamics simulations, and protein modeling using software like GROMACS and AutoDock. Dr. Abdi’s comprehensive skill set enables him to approach research problems from multiple angles, integrating molecular biology, toxicology, and computational methods for impactful outcomes.
📚 Publications
Mitochondrial Dysfunction Induced by Bisphenol A is a Factor of its Hepatotoxicity in Rats
- Journal: Environmental Toxicology
- Year: 2016
- Citations: 115
Study of Drug Utilization Pattern of Antihyperglycemic Agents in a South Indian Tertiary Care Teaching Hospital
- Journal: Indian Journal of Pharmacology
- Year: 2012
- Citations: 61
Multi-Epitope-Based Vaccine Candidate for Monkeypox: An In Silico Approach
- Journal: Vaccines
- Year: 2022
- Citations: 32
The Protective Effect of α-Lipoic Acid Against Bisphenol A-Induced Neurobehavioral Toxicity
- Journal: Neurochemistry International
- Year: 2018
- Citations: 29
Anti-Inflammatory Role of Tempol (4-Hydroxy-2, 2, 6, 6-Tetramethylpiperidin-1-Oxyl) in Nephroprotection
- Journal: Human & Experimental Toxicology
- Year: 2019
- Citations: 14
Cyclophosphamide-Induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine
- Journal: Basic & Clinical Pharmacology & Toxicology
- Year: 2016
- Citations: 13
Sunscreen Ingredient Octocrylene’s Potency to Disrupt Vitamin D Synthesis
- Journal: International Journal of Molecular Sciences
- Year: 2022
- Citations: 12
Conclusion
Dr. Sayed Abdi is a strong contender for the “Research for Best Researcher Award” due to his outstanding educational background, diverse research experience, technical expertise, and impactful contributions to toxicology and pharmaceutical sciences. With further emphasis on high-impact publications, grant acquisition, and leadership roles, he can elevate his already impressive profile to new heights.